ZATTONI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 6.059
AS - Asia 1.146
EU - Europa 850
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 8.064
Nazione #
US - Stati Uniti d'America 6.046
CN - Cina 512
IT - Italia 381
SG - Singapore 374
VN - Vietnam 187
FR - Francia 99
FI - Finlandia 93
DE - Germania 75
GB - Regno Unito 47
SE - Svezia 45
IE - Irlanda 32
IN - India 21
CH - Svizzera 18
JP - Giappone 17
NL - Olanda 14
CA - Canada 9
ES - Italia 9
HK - Hong Kong 9
ID - Indonesia 7
UA - Ucraina 7
RU - Federazione Russa 6
TR - Turchia 5
GR - Grecia 4
PL - Polonia 4
BG - Bulgaria 3
BR - Brasile 3
MX - Messico 3
PH - Filippine 3
AR - Argentina 2
AT - Austria 2
KR - Corea 2
LU - Lussemburgo 2
MY - Malesia 2
OM - Oman 2
RO - Romania 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
EC - Ecuador 1
EU - Europa 1
IR - Iran 1
KH - Cambogia 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 8.064
Città #
Fairfield 1.199
Woodbridge 536
Ashburn 502
Chandler 474
Seattle 430
Houston 414
Cambridge 387
Wilmington 370
Ann Arbor 317
Singapore 294
Dong Ket 185
San Diego 139
Princeton 119
Medford 117
Beijing 112
Des Moines 90
Padova 89
Guangzhou 78
Helsinki 67
Roxbury 57
Santa Clara 51
Nanjing 46
Milan 37
Boardman 33
Shanghai 32
Dublin 29
New York 22
Nanchang 19
Rome 19
Jinan 17
Falls Church 16
Zurich 15
Shenyang 14
Hebei 13
Tianjin 13
Jacksonville 12
Legnago 12
Ogden 11
London 10
Paris 10
Hefei 9
Jiaxing 9
Malo 9
Norwalk 9
Pune 9
Florence 8
Hong Kong 8
Venice 8
Prescot 7
Trieste 7
Viterbo 7
Washington 7
Bonn 6
Cagliari 6
Detroit 6
Hangzhou 6
Hounslow 6
Lappeenranta 6
Pignone 6
Zhengzhou 6
Bologna 5
Dallas 5
Frankfurt am Main 5
Mira 5
Naples 5
Taiyuan 5
Amsterdam 4
Borås 4
Changsha 4
Chicago 4
Fuzhou 4
Haikou 4
Los Angeles 4
Molinara 4
Rockville 4
Taizhou 4
Tokyo 4
Vicenza 4
Americana 3
Arezzo 3
Azzano Decimo 3
Conegliano 3
Dearborn 3
Delhi 3
Esslingen am Neckar 3
Jakarta 3
Kharkiv 3
Kunming 3
Lauria 3
Leawood 3
Montreal 3
New Bedfont 3
Noordwijk aan Zee 3
Noventa 3
Palermo 3
Phoenix 3
Preganziol 3
Abano Terme 2
Ames 2
Ankara 2
Totale 6.693
Nome #
A 10-year history of secondary hypertension: A challenging case of renin-secreting juxtaglomerular cell tumor 185
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 163
The Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy 162
The value of open conversion simulations during robot-assisted radical prostatectomy: Implications for robotic training curricula 154
Complex cystine kidney stones treated with combined robot-assisted laparoscopic pyelolithotomy and intraoperative renoscopy 146
Spermatic Cord Sarcoma: Our Experience and Review of the Literature 122
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 122
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [18F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis 120
Technical innovations to optimize continence recovery after robotic assisted radical prostatectomy 119
PET/MRI in prostate cancer: a systematic review and meta-analysis 116
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 115
Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer 115
Ultrasound-guided transversus abdominis plane block (US-TAPb) for robot-assisted radical prostatectomy: a novel ‘4-point’ technique—results of a prospective, randomized study 114
18F-fluoromethylcholine or 18F-fluoroethylcholine pet for prostate cancer imaging: Which is better? A literature revision 106
Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy 105
MP79-02 EVALUATION OF THE PROGNOSTIC IMPACT OF 18F-CHOLINE PET/CT IN PATIENTS WITH SKELETAL RECURRENCE PROSTATE CANCER 104
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT 99
Histopathological characteristics of microfocal prostate cancer detected during systematic prostate biopsy. 99
PD11-01 COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI-CENTER STUDY 95
Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma 92
Effect of allogeneic intraoperative blood transfusion on survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution 92
Can 68GA-PSMA or radiolabeled choline PET/CT guide salvage lymph node dissection in recurrent prostate cancer? 92
Combined robotic-assisted retroperitoneoscopic partial nephrectomy and extraperitoneal prostatectomy. First case reported. 90
Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review. 90
Why and How to Evaluate Chronic Prostatic Inflammation 87
THE WAR IS OPENED: PSMA VS. 64CuCL2 VS. CHOLINE PET/CT 85
THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES 84
ULTRASOUND DETECTED NON-PALPABLE TESTICULAR LESIONS: WHAT DO YOU DO? 83
PD36-03 PERIOPERATIVE OUTCOMES OF OPEN RADICAL CYSTECTOMY IN OCTOGENARIANS: RESULTS FROM TWO HIGH-VOLUME CENTRES 82
Global minimally invasive pyeloplasty study in children: Results from the Pediatric Urology Expert Group of the European Association of Urology Young Academic Urologists working party 82
Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial. 81
Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer 79
Development of a Surgical Safety Training Program and Checklist for Conversion during Robotic Partial Nephrectomies 76
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil 76
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) 75
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 75
Correlation between pathologic features and perfusion CT of renal cancer: a feasibility study. 74
Endourologic Diagnosis and Robotic Treatment of a Giant Fibroepithelial Polyp of the Ureter 74
Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse 74
Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy 74
Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy 73
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis. 73
THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES 73
68Ga-dotatoc vs.18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patients 73
MP55-05 PARTIAL NEPHRECTOMY IN THE TREATMENT OF RENAL TUMORS WITH CONCOMITANT VENOUS TUMOR THROMBOSIS (VTT) OF RENAL VEIN BRANCHES: RETROSPECTIVE, MULTI-CENTER ANALYSIS OF PERIOPERATIVE, FUNCTIONAL, AND ONCOLOGIC OUTCOMES 72
The Endourological Treatment of Renal Matrix Stones 71
Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results 71
Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg? 70
Prostate cancer: more effective use of underutilized postoperative radiation therapy 69
Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy 68
Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. 68
Income inequality and treatment of African American men with high-risk prostate cancer 67
Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup 67
Posterior muscolofascial reconstruction incorporated into urethrovescical anastomosis during robot-assisted radical prostatectomy 67
MP59-08 EXTERNAL VALIDATION OF RENAL TUMOUR CONTACT SURFACE AREA (CSA) IN PATIENTS WHO UNDERWENT PARTIAL NEPHRECTOMY 67
PD32-08 CHOLINE PET/CT SCAN FOR THE DETECTION OF NODAL RELAPSES OF PROSTATE CANCER AFTER BIOCHEMICAL RECURRENCE: RESULTS FROM A MULTICENTRIC STUDY 66
Perioperative outcomes and early survival in octogenarians who underwent radical cystectomy for bladder cancer 65
Risk stratification for benign prostatic hyperplasia 64
PD19-01 THE VALUE OF OPEN CONVERSION SIMULATIONS DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: IMPLICATIONS FOR ROBOTIC TRAINING CURRICULUMS 63
The impact of COVID-19 pandemic on pornography habits: a global analysis of Google Trends 63
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 62
MP53-14 MULTIMODAL TREATMENT FOR HIGH-RISK PROSTATE CANCER WITH HIGH-DOSE INTENSITY-MODULATED RADIATION THERAPY, CONCURRENT INTENSIFIED-DOSE DOCETAXEL AND LONG-TERM ANDROGEN DEPRIVATION THERAPY AFTER RADICAL PROSTATECTOMY AND LYMPHADENECTOMY: RESULTS OF A PROSPECTIVE PHASE II TRIAL 62
MP57-13 LAPAROSCOPIC VERSUS PERCUTANEOUS CRYOABLATION FOR T1 RENAL MASSES: AN ITALIAN MULTICENTRIC STUDY 61
Treating cervico-urethral obstructions with laser diode: initial clinical experience. 60
Erratum: Why and how to evaluate chronic prostatic inflammation (European Urology (2013) 12:SUPPL. (110-5)) 60
Wunderlich's syndrome: three cases of acute spontaneous renal bleeding, conservatively treated. 59
The future of choline pet in the era of PMSA 59
Transitional cell carcinoma recurrence impacting intestinal diversion after radical cystectomy. Oncologic outcomes of a rare site of recurrence 59
Radiotherapy and concomitant docetaxel in high risk prostatic cancer:guone (north east uro oncology group) experience. 57
PD12-12 COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES 57
Should radical prostatectomy be encouraged at any age? A critical non-systematic review 55
PET/CT and urinary cancers: the message from urologists 54
Is "extreme" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure? 54
RETROGRADE INTRA RENAL SURGERY (RIRS) FOR RENAL STONES 53
Re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive68Ga Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926–37 52
PD43-04 COMPARING THE 8-YEAR ONCOLOGIC OUTCOMES OF OPEN AND ROBOT-ASSISTED RADICAL PROSTATECTOMY FOR HIGH RISK PROSTATE CANCER 52
MP69-05 ONCOLOGIC OUTCOMES AND BIOCHEMICAL PREDICTORS FOLLOWING SALVAGE LYMPH NODE DISSECTION FOR PROSTATE CANCER 51
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 50
MP53-07 NEED FOR A SURGICAL TEMPLATE IN SALVAGE LYMPHADENECTOMY FOR NODAL RECURRENCE OF PROSTATE CANCER: IS PELVIC INVOLVEMENT PREDICTIVE OF RETROPERITONEAL POSITIVITY? 50
RETROGRADE INTRA RENAL SURGERY FOR RENAL STONES 50
Minimally invasive urologic surgery is safe during COVID-19: experience from two high-volume centers in Italy 49
CLINICAL EVOLUTION OF THE RENAL COLIC. AN OBSERVATIONAL STUDY 46
COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI-CENTER STUDY 46
Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis 46
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 45
Focal Therapy for Prostate Cancer: Complications and Their Treatment 44
Metabolic syndrome and stone disease 41
Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: A systematic review and meta-analysis 40
Metabolic syndrome and prostate cancer treatment 40
VE05 - How is a neobladder born? Ves.Pa.: ‘From lab to fab’ 39
Re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926-37 36
Comparison between conventional imaging (CI) and wholebody 18F-choline (FCH) positron emission tomography/ computed tomography (PET/CT) in patients (pts) with prostate cancer (PCa) 35
The Future of Choline PET in the Era of Prostate Specific Membrane Antigen 35
MP67-14 PREDICTIVE VALUE OF NEGATIVE 3T MULTIPARAMETRIC PROSTATE MRI ON 12 CORE BIOPSY RESULTS 33
Other than restaging phase: serial FCH-PET/CT scans can predict the reponse to chemotherapy (CT) in castrate-resistant prostate cancer (CRPCa)? 32
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer 32
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 30
THE EFFECT OF PRIOR TURP ON COMPLICATIONS AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY: A 25-YEAR SINGLE INSTITUTION EXPERIENCE 30
Endourological management of uretero-ileal anastomosis stricture after cystectomy and Vescica Ileale Padovana (V.I.P.) orthotopic neobladder reconstruction 30
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer 30
Totale 7.324
Categoria #
all - tutte 39.206
article - articoli 37.447
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.520 0 0 0 176 282 137 180 205 214 163 104 59
2020/20211.151 54 74 81 137 33 57 57 93 128 114 104 219
2021/20221.556 45 183 162 87 66 158 127 132 68 76 119 333
2022/20231.091 238 82 20 112 157 137 26 66 120 10 87 36
2023/20241.022 43 106 98 64 58 85 80 64 58 131 118 117
2024/2025650 24 315 164 147 0 0 0 0 0 0 0 0
Totale 8.283